Literature DB >> 2548476

Folate (pteroylglutamate) uptake in human red blood cells, erythroid precursors and KB cells at high extracellular folate concentrations. Evidence against a role for specific folate-binding and transport proteins.

A C Antony1, M A Kane, S R Krishnan, R S Kincade, R S Verma.   

Abstract

Membrane-associated folate (pteroylglutamate, PteGlu)-binding proteins (FBPs) play an important role as PteGlu-transport proteins in malignant and normal human cells. Since high extracellular folate (PteGlu) concentrations (EFC) profoundly influenced uptake and toxicity of the anti-PteGlu methotrexate in malignant KB cells, we studied human cells to determine additional mechanisms for PteGlu uptake when the EFC was varied. At low EFC (less than 10 nM), the predominant mechanism for folate uptake in mature erythrocytes was through binding to externally oriented FBPs which were quantitatively insignificant (4-6 orders of magnitude lower) and of no apparent physiological relevance when compared with KB cells. However, the predominant mechanism of PteGlu accumulation at high EFC [10-250 nM] in intact erythrocytes and sealed right-side-out (RSO) ghosts was not FBP-mediated and non-specific. This conclusion was based on the findings that radiolabelled PteGlu uptake: (i) continued even in the presence of a 1000-fold excess of unlabelled PteGlu and was linear and not saturable up to 250 nM; (ii) was two-fold higher at pH 4.5 than 7.5; (iii) was less than 2-fold increased at 37 degrees C compared with 4 degrees C; and (iv) was unaffected after trypsin-mediated proteolysis of greater than 75% FBPs. The [3H]PteGlu and 125I-PteGlu (histamine derivative) accumulated intracellularly through the non-specific PteGlu-uptake mechanism was unaltered biochemically and in a soluble compartment. Raising the EFC 500-fold higher than controls during erythropoiesis in vitro resulted in reversal of the expected anti-(placental folate-receptor)-antiserum-induced megaloblastic changes in orthochromatic normoblasts derived from burst-forming unit-erythroid colonies. Furthermore, at EFC greater than 0.1 microM, KB-cell accumulation of [3H]PteGlu was also predominantly through a mechanism that did not involve specific FBPs. Thus, at high EFC, a major component of PteGlu transport in human cells is not mediated through FBPs and is likely to be a passive diffusion process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548476      PMCID: PMC1138683          DOI: 10.1042/bj2600401

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  The removal of leukocytes and platelets from whole blood.

Authors:  E Beutler; C West; K G Blume
Journal:  J Lab Clin Med       Date:  1976-08

2.  Transport of methotrexate into normal haemopoietic cells and into leukaemic cells and its effects on DNA synthesis.

Authors:  V Hoffbrand; E Tripp; D Catovsky; K C Das
Journal:  Br J Haematol       Date:  1973-10       Impact factor: 6.998

3.  Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes.

Authors:  T L Steck; J A Kant
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Uptake of tritiated folates by human bone marrow cells in vitro.

Authors:  J J Corcino; S Waxman; V Herbert
Journal:  Br J Haematol       Date:  1971-05       Impact factor: 6.998

6.  Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells.

Authors:  A C Antony; M A Kane; R M Portillo; P C Elwood; J F Kolhouse
Journal:  J Biol Chem       Date:  1985-12-05       Impact factor: 5.157

7.  Folate-induced remission in aplastic anemia with familial defect of cellular folate uptake.

Authors:  R F Branda; C F Moldow; J R MacArthur; M M Wintrobe; B K Anthony; H S Jacob
Journal:  N Engl J Med       Date:  1978-03-02       Impact factor: 91.245

8.  The mechanism of 5-methyltetrahydrofolate transport by human erythrocytes.

Authors:  R F Branda; B K Anthony; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

9.  Identification of folate binding proteins in rat liver.

Authors:  M M Zamierowski; C Wagner
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

10.  The mechanism of folate transport in rabbit reticulocytes.

Authors:  W F Bobzien; I D Goldman
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

View more
  5 in total

1.  Transduction of folate receptor cDNA into cervical carcinoma cells using recombinant adeno-associated virions delays cell proliferation in vitro and in vivo.

Authors:  X L Sun; B R Murphy; Q J Li; S Gullapalli; J Mackins; H N Jayaram; A Srivastava; A C Antony
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

2.  Megaloblastic hematopoiesis in vitro. Interaction of anti-folate receptor antibodies with hematopoietic progenitor cells leads to a proliferative response independent of megaloblastic changes.

Authors:  A C Antony; R A Briddell; J E Brandt; J E Straneva; R S Verma; M E Miller; L A Kalasinski; R Hoffman
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

3.  Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis.

Authors:  Carola Huthmacher; Andreas Hoppe; Sascha Bulik; Hermann-Georg Holzhütter
Journal:  BMC Syst Biol       Date:  2010-08-31

4.  Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions.

Authors:  Aśok Antony; Ying-Sheng Tang; Rehana A Khan; Mangatt P Biju; Xiangli Xiao; Qing-Jun Li; Xin-Lai Sun; Hiremagalur N Jayaram; Sally P Stabler
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

5.  Relationship between folate-binding protein expression and cisplatin sensitivity in ovarian carcinoma cell lines.

Authors:  F Ottone; S Miotti; C Bottini; M Bagnoli; P Perego; M I Colnaghi; S Ménard
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.